Avantor Performance Materials expands presence in India
Adds new pilot plant and applications lab to support customers in Southeast Asia
Avantor Performance Materials has opened a new pharmaceuticals formulation applications laboratory at the RanQ Remedies facility, an excipient developer and manufacturer based in Sinnar Nashik, India.
The move follows Avantor’s recent acquisition of RFCL in India, and demonstrates the company’s commitment to growth and expansion in the region.
The new lab, which strengthens a development and manufacturing agreement between Avantor and RanQ, will be used to characterise excipients; perform functional testing; develop and characterise drug formulations; and support customer applications and product implementation.
In addition to the laboratory, Avantor has built a pilot plant at the RanQ facility, which will be used to develop and scale up additional performance excipients to extend the company’s J T Baker PanExcea product line. This line includes excipients that combine filler, binder and disintegrant to provide increased excipient functionality for immediate release and orally disintegrating tablets.
‘Our partnership with Avantor will allow us to advance our goal of becoming an internationally known, high-quality excipient manufacturer,’ said Sameer Ranadive, managing director of RanQ.
‘With our proven excipient innovation experience, beaker-to-bulk packaging flexibility and Q7A quality systems, RanQ will serve as a strategic pharmaceutical partner in the region,’ commented Paul Smaltz, Avantor’s executive vp of pharmaceuticals.